Abstract—
Alcoholism is a global socially significant problem, which still remains one of the leading causes of disability and premature death. One of the main signs of the disease is the loss of cognitive control over the amount of alcohol consumed. Among the mechanisms of the development of this pathology, changes in neuroimmune mechanisms occurring in the brain during prolonged alcohol consumption and its withdrawal have recently become in the focus of numerous studies. Ethanol consumption leads to the activation of neuroimmune signaling in the central nervous system through many subtypes of Toll-like receptors (TLRs), as well as release of their endogenous agonists (HMGB1 protein, S100 protein, heat shock proteins, extracellular matrix degradation proteins). TLR activation triggers intracellular molecular cascades of reactions leading to increased expression of genes of the innate immune system, particularly, proinflammatory cytokines, causing further development of a persistent neuroinflammatory process in the central nervous system, which leads to death of neurons and neuroglial cells in various brain structures, primarily in those, which are associated with the development of a pathological craving for alcohol. In addition, there is evidence that some subtypes of TLRs (TLR3, TLR4) are able to form heterodimers with neuropeptide receptors, thereby possibly playing other roles in the central nervous system, in addition to participating in the activation of the innate immune system.
Similar content being viewed by others
REFERENCES
Lewohl, J.M., Wang, L., Miles, M.F., Zhang, L., Dodd, P.R., and Harris, R.A., Alcoholism: Clinical and Experimental Research, 2000, vol. 24, no. 12, pp. 1873–1882.
Valles, S.L., Blanco, A.M., Pascual, M., and Guerri, C., Brain Pathol., 2004, vol. 14, no. 4, pp. 365–371.
Crews, F.T., Zou, J., and Qin, L., Brain, Behavior, and Immunity, 2011, vol. 25, pp. S4–S12. https://doi.org/10.1016/j.bbi.2011.03.003
Crews, F.T. et al., Biological Psychiatry, 2013, vol. 73, no. 7, pp. 602–612. https://doi.org/10.1016/j.biopsych.2012.09.030
Crews, F.T. and Vetreno, R.P., Int. Rev. Neurobiol., 2014, vol. 118, pp. 315–357. https://doi.org/10.1016/b978-0-12-801284-0.00010-5
Crews, F.T. and Vetreno, R.P., Psychopharmacology, 2015, vol. 233, no. 9, pp. 1543–1557. https://doi.org/10.1007/s00213-015-3906-1
Crews, F.T., Walter, T.J., Coleman, L.G., and Vetreno, R.P., Psychopharmacology, 2017, vol. 234, nos. 9–10, pp. 1483–1498. https://doi.org/10.1007/s00213-017-4560-6
Vetreno, R.P. and Crews, F.T., Alcohol and the Nervous System. Handbook of Clinical Neurology, 2014, pp. 477–497. https://doi.org/10.1016/b978-0-444-62619-6.00027-6
Airapetov, M.I., Sexte, E.A., Eresko, S.O., Bychkov, E.R., Lebedev, A.A., and Shabanov, P.D., Biomed. Khimiya, 2018, vol. 64, no. 5, pp. 451–454. https://doi.org/10.18097/PBMC20186405451
Airapetov, M.I., Eresko, S.O., Bychkov, E.R., Lebedev, A.A., and Shabanov, P.D., Medical Immunology, 2020, vol. 22, no. 1, pp. 77–86. https://doi.org/10.15789/1563-0625-EOT-1836
Eryshev, O.F., Rybakova, T.G., and Shabanov, P.D. Alkogol’naya zavisimost’: formirovanie, techenie, protivoretsidivnaya terapia (Alcohol Dependence: Formation, Course, Anti-Relapse Therapy), St. Petersburg: Elby-SPb, 2002.
Shabanov, P.D. and Kalishevich S.Yu. Biologiya alkogolizma (Biology of Alcoholism), St. Petersburg: Lan’, 1998.
Shabanov, P.D., Lebedev, A.A., and Streltsov, V.F., Gormonal’nye mekhanizmy podkrepleniya (Hormonal Mechanisms of Reinforcement), St. Petersburg: Elby-SPb, 2008.
Becker, H.C., Alcohol and the Nervous System. Handbook of Clinical Neurology, 2014, vol. 125, pp. 133–156.
Walter, T.J., Vetreno, R.P., and Crews, F.T., Alcoholism: Clinical and Experimental Research, 2017, vol. 41, no. 12, pp. 2066–2081. https://doi.org/10.1111/acer.13511
Graeber, M.B., Li, W., and Rodriguez, M.L., FEBS Letts., 2011, vol. 585, no. 23, pp. 3798–3805. https://doi.org/10.1016/j.febslet.2011.08.033
Hanke, M.L. and Kielian, T., Clinical Science, 2011, vol. 121, no. 9, pp. 367–387. https://doi.org/10.1042/cs20110164
Lebedev, K.A. and Ponyakina, I.D., Immunologiya obrazraspoznayushchikh receptorov (Immunology of Image Recognizing Receptors), Moscow: Lenand, M., 2017.
Crews, F.T., Braun, C.J., Hoplight, B., Switzer, R.C., and Knapp, D.J., Alcoholism: Clinical and Experimental Research, 2000, vol. 24, no. 11, pp. 1712–1723. https://doi.org/10.1111/j.1530-0277.2000.tb01973.x
Zou, J. and Crews, F., Alcoholism: Clinical and Experimental Research, 2010, vol. 34, no. 5, pp. 777–789. https://doi.org/10.1111/j.1530-0277.2010.01150.x
Zou, J. and Crews, F.T., Front. Neurosci., 2012, vol. 6, 77. https://doi.org/10.3389/fnins.2012.00077
Qin, L. and Crews, F.T., J. Neuroinflammation, 2012, vol. 9, no. 1, 130. https://doi.org/10.1186/1742-2094-9-130
Blednov, Y.A., Benavidez, J.M., Geil, C., Perra, S., Morikawa, H., and Harris, R.A., Brain, Behavior, and Immunity, 2011, vol. 25, pp. S92–S105. https://doi.org/10.1016/j.bbi.2011.01.008
Qin, L. et al., J. Neuroinflammation, 2008, vol. 5, no. 1, 10. https://doi.org/10.1186/1742-2094-5-10
Qin, L., Liu, Y., Hong, J.S., and Crews, F.T., Glia, 2013, vol. 61, no. 6, pp. 855–868. https://doi.org/10.1002/glia.22479
Lawrimore, C.J. and Crews, F.T., Alcoholism: Clinical and Experimental Research, 2017, vol. 41, no. 5, pp. 939–954. https://doi.org/10.1111/acer.13368
Alfonso-Loeches, S. and Guerri, C., Crit. Revs. Clin. Lab. Sci., 2011, vol. 48, no. 1, pp. 19–47. https://doi.org/10.3109/10408363.2011.580567
Fernandez-Lizarbe, S., Pascual, M., and Guerri, C., J. Immunol., 2009, vol. 183, no.7, pp. 4733–4744. https://doi.org/10.4049/jimmunol.0803590
Pascual, M., Balino, P., Alfonso-Loeches, S., Aragon, C.M., and Guerri, C., Brain, Behavior, and Immunity, 2011, vol. 25, pp. S80–S91. https://doi.org/10.1016/j.bbi.2011.02.012
Yamamoto, M., Sato, S., Mori, K., et al., J. Immun., 2002, vol. 169, no. 12, pp. 6668–6672. https://doi.org/10.4049/jimmunol.169.12.6668
Esen, N., and Kielian, T., in Toll-Like Receptors in Brain Abscess. Toll-Like Receptors: Roles in Infection and Neuropathology, 2009, pp. 41–61. https://doi.org/10.1007/978-3-642-00549-7_3
Leifer, C.A. and Medvedev, A.E., J. Leukocyte Biol., 2016, vol. 100, no. 5, pp. 927–941. https://doi.org/10.1189/jlb.2mr0316-117rr
Nie, L., Cai, S.Y., Shao, J.Z., and Chen, J., Front. Immunol., 2018, vol. 9.https://doi.org/10.3389/fimmu.2018.01523
Vabulas, R.M., Wagner, H., and Schild, H., Curr. Top Microbiol. Immunol., 2002, vol. 270, pp. 169–184. https://doi.org/10.1007/978-3-642-59430-4_11
kun, E., Griffioen, K.J., Lathia, J.D., Tang, S.C., Mattson, M.P., and Arumugam, T.V., Brain Res. Rev., 2009, vol. 59, no. 2, pp. 278–292. 10.1016/j.brainresrev.2008.09.00
Coleman, L.G., Zou, J., and Crews, F.T., J. Neuroinflammation, 2017, vol. 14, no. 1.https://doi.org/10.1186/s12974-017-0799-4
Pascual, M., Baliño, P., Aragón, C.M.G., and Guerri, C., Neuropharmacology, 2015, vol. 89, pp. 352–359. https://doi.org/10.1016/j.neuropharm.2014.10.014
Qin, L., Wu, X., Block, M.L., Liu, Y., Breese, G.R., Hong, J.S., Knapp, D.J., and Crews, F.T., Glia, 2007, vol. 55, vol. 5, pp. 453–462. https://doi.org/10.1002/glia.20467
Kovalchuk, L.V., Khoreva, M.V., and Varvoda, A.S., Journal of Microbiology, Epidemiology and Immunology, 2005, vol. 4, pp. 96–104.
Volkov, M.Y., Rheumatology Science and Practice, 2016, vol. 54, no. 1, pp. 78–85. https://doi.org/10.14412/1995-4484-2016-78-85
Takagi, M., Takakubo, Y., Pajarinen, J., Naganuma, Y., Oki, H., Maruyama, M., and Goodman, S.B., J. Orthopaedic Translation, 2017, vol. 10, pp. 68–85. https://doi.org/10.1016/j.jot.2017.05.004
Jang, T.H., Badri Narayanan, K., Ho Park, H., Protein & Peptide Letters, 2015, vol. 23, no. 1, pp. 55–62. https://doi.org/10.2174/0929866523666151106123613
Murphy, K. and Weaver, C., Janeway’s Immunobiology, 9th ed., New York: Garland Science (Taylor & Francis Group), 2017.
Akira, S. and Takeda, K., Nat. Rev. Immunol., 2004, vol. 4, no. 7, pp. 499–511. https://doi.org/10.1038/nri1391
Smith, K.M., Eaton, A.D., Finlayson, L.M., et al., Am. J. Respir. Crit. Care Med., 2000, vol. 162, no. 4, pp. 343–356. https://doi.org/10.1164/ajrccm.162.supplement_3.15tac7
Sinch-Jasuja, H., Hilf, N., Arnold-Schild, D., and Schild, H., Biol. Chem., 2001, vol. 382, no. 4, pp. 629–639. https://doi.org/10.1515/bc.2001.074
Fitzgerald, K., Rowe, D., Barnes, B., et al., J. Exp. Med., 2003, vol. 198, no. 7, pp. 1043–1055. https://doi.org/10.1084/jem.20031023
Nilsen, N., Nonstad, U., Klan, N., et al., J. Biol. Chem., 2004, vol. 279, no. 38, pp. 39727–39735. https://doi.org/10.1074/jbc.M40502720
An, H., Zhao, W., Hou, J., et al., Immunity, 2006, vol. 25, no. 6, pp. 919–928. https://doi.org/10.1016/j.immuni.2006.10.014
Lee, M.C. and Kim, Y.J., Annu. Rev. Biochem., 2007, vol. 76, pp. 447–480. https://doi.org/10.1146/annurev.biochem.76.060605.122847
Napolitani, G., Rnaldi, A., and Bertoni, F., Nat. Immunol., 2005, vol. 6, no. 8, pp. 769–776. https://doi.org/10.1038/ni1223
Wang, J., Shao, Y., Benett, T.A., et al., J. Biol. Chem., 2006, vol. 281, no. 49, pp. 37427–37434. https://doi.org/10.1074/jbc.M605311200
Scheibner, K.A., Lutz, M.A., Boodoo, S., Fenton, M.J., Powell, J.D., and Horton, M.R., J. Immunol., 2006, vol. 177, no. 2, pp. 1272–1281. https://doi.org/10.4049/jimmunol.177.2.1272
McCarthy, G.M., Warden, A.S., Bridges, C.R., Blednov, Y.A., and Harris, R.A., Addiction Biology, 2018, vol. 23, no. 3, pp. 889–903. https://doi.org/10.1111/adb.12539
Warden, A.S., Azzam, M., DaCosta, A., Mason, S., Blednov, Y.A., Messing, R.O., and Harris R.A., Brain, Behavior, and Immunity, 2019, vol. 77, pp. 66–76. https://doi.org/10.1016/j.bbi.2018.12.006
Randall, P.A., Vetreno, R.P., Makhijani, V.H., Crews, F.T., and Besheer, J., Alcoholism: Clinical and Experimental Research, 2019, vol. 43, no. 1, pp. 48–60. https://doi.org/10.1111/acer.13919
Lawrimore, C.J., Coleman, L.G., and Crews, F.T., Psychopharmacology, 2019, vol. 4.https://doi.org/10.1007/s00213-018-5153-8
Liu, J., Yang, A.R., Kelly, T., Puche, A., Esoga, C., June, H.L., and Aurelian, L., Proc. Nat. Acad. Sci. USA, 2011, vol. 108, no. 11, pp. 4465–4470. https://doi.org/10.1073/pnas.1019020108
Blednov, Y.A., Black, M., Benavidez, J.M., Da Costa, A., Mayfield, J., and Harris, R.A., Alcoholism: Clinical and Experimental Research, 2017, vol. 41, no. 3, pp. 531–540. https://doi.org/10.1111/acer.13314
Harris, R.A., Bajo, M., Bell, R.L., Blednov, Y.A., Varodayan, F.P., Truitt, J.M., and Homanics, G.E., J. Neuroscience, 2016, vol. 37, no. 5, pp. 1139–1155. https://doi.org/10.1523/JNEUROSCI.2002-16.2016
June, H.L., Liu, J., Warnock, K.T., Bell, K.A., Balan, I., Bollino, D., and Aurelian, L., Neuropsychopharmacology, 2015, vol. 40, no. 6, pp. 1549–1559. https://doi.org/10.1038/npp.2015.4
Pla, A., Pascual, M., Renau-Piqueras, J., and Guerri, C., Cell Death Dis., 2014, vol. 5, no. 2, e1066. https://doi.org/10.1038/cddis.2014.46
Montesinos, J., Alfonso-Loeches, S., and Guerri, C., Alcoholism: Clinical and Experimental Research, 2016, vol. 40, no. 11, pp. 2260–2270. https://doi.org/10.1111/acer.13208
Montesinos, J., Pascual, M., Pla, A., Maldonado, C., Rodríguez-Arias, M., Miñarro, J., and Guerri, C., Brain, Behavior, and Immunity, 2015, vol. 45, pp. 233–244. https://doi.org/10.1016/j.bbi.2014.11.015
Alfonso-Loeches, S., Pascual-Lucas, M., Blan-co, A.M., Sanchez-Vera, I., and Guerri, C., J. Neurosci., 2010, vol. 30, no. 24, pp. 8285–8295. https://doi.org/10.1523/jneurosci.0976-10.2010
He, J. and Crews, F.T., Experimental Neurology, 2008, vol. 210, no. 2, pp. 349–358. https://doi.org/10.1016/j.expneurol.2007.11.017
Breese, G.R., Knapp, D.J., Overstreet, D.H., Navarro, M., Wills, T.A., and Angel, R.A., Neuropsychopharmacology, 2008, vol. 33, no. 7, pp. 867–876. https://doi.org/10.1038/sj.npp.1301514
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
COMPLIANCE WITH ETHICAL STANDARDS
This article does not contain any research involving humans or the use of animals as objects.
CONFLICT OF INTEREST
The authors declare that they have no conflicts of int-erest.
Additional information
Translated by A. Medvedev
Rights and permissions
About this article
Cite this article
Airapetov, M.I., Eresko, S.O., Lebedev, A.A. et al. The Role of Toll-Like Receptors in Neuroimmunology of Alcoholism. Biochem. Moscow Suppl. Ser. B 15, 71–79 (2021). https://doi.org/10.1134/S1990750821010029
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1990750821010029